FR2888507B1 - USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCER - Google Patents
USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCERInfo
- Publication number
- FR2888507B1 FR2888507B1 FR0507481A FR0507481A FR2888507B1 FR 2888507 B1 FR2888507 B1 FR 2888507B1 FR 0507481 A FR0507481 A FR 0507481A FR 0507481 A FR0507481 A FR 0507481A FR 2888507 B1 FR2888507 B1 FR 2888507B1
- Authority
- FR
- France
- Prior art keywords
- sertraline
- alkaloid
- cancer
- treatment
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0507481A FR2888507B1 (en) | 2005-07-12 | 2005-07-12 | USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCER |
PCT/EP2006/064159 WO2007006799A1 (en) | 2005-07-12 | 2006-07-12 | Use of sertraline in combination with an alkaloid for treating cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0507481A FR2888507B1 (en) | 2005-07-12 | 2005-07-12 | USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCER |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2888507A1 FR2888507A1 (en) | 2007-01-19 |
FR2888507B1 true FR2888507B1 (en) | 2007-10-05 |
Family
ID=35840562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0507481A Expired - Fee Related FR2888507B1 (en) | 2005-07-12 | 2005-07-12 | USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCER |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2888507B1 (en) |
WO (1) | WO2007006799A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3071726B1 (en) * | 2017-09-29 | 2020-09-04 | Univ Paris Sud | TCTP PROTEIN INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES |
WO2020043716A1 (en) | 2018-08-27 | 2020-03-05 | Katholieke Universiteit Leuven | Pharmacological targeting of de novo serine/glycine synthesis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6761895B2 (en) * | 2000-04-17 | 2004-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
CA2308994A1 (en) * | 2000-05-19 | 2001-11-19 | Aegera Therapeutics Inc. | Neuroprotective compounds |
US20040072824A1 (en) * | 2001-06-01 | 2004-04-15 | Adam Telerman | Methods and compositions for the treatment of cancer |
-
2005
- 2005-07-12 FR FR0507481A patent/FR2888507B1/en not_active Expired - Fee Related
-
2006
- 2006-07-12 WO PCT/EP2006/064159 patent/WO2007006799A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR2888507A1 (en) | 2007-01-19 |
WO2007006799A1 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE429585T1 (en) | PIPING | |
CR10699A (en) | WNT ANTAGONISTS AND ITS USE IN THE DIAGNOSIS AND TREATMENT OF WNT-USED DISORDERS | |
FR2907011B1 (en) | USE OF CITRULLINE FOR THE TREATMENT OF DENUTRITION CONDITIONS | |
ATE521365T1 (en) | KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER | |
HK1146596A1 (en) | Use of lingo-4 antagonists in the treatment of conditions involving demyelination lingo-4 | |
BRPI0809272A2 (en) | BIARIL AND BIHETEROARIL COMPOUNDS IN THE TREATMENT OF IRON DISORDERS | |
FR2915102B1 (en) | USE OF ANTI-CXCR4 ANTIBODY FOR THE TREATMENT OF CANCER | |
FR2899476B1 (en) | ASSOCIATION OF MAZINDOL IN THE TREATMENT OF DEFICIT ATTENTION / HYPERACTIVITY | |
FR2900341B1 (en) | USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN FOR THE TREATMENT OF CANCER | |
DE502005007027D1 (en) | Combined bath and shower device | |
HK1134032A1 (en) | New combination for use in the treatment of inflammatory disorders | |
NO20043033L (en) | Piping | |
FR2888507B1 (en) | USE OF SERTRALINE IN COMBINATION WITH ALKALOID FOR THE TREATMENT OF CANCER | |
FR2868312B1 (en) | PATCH FOR THE TREATMENT OF LIP | |
FR2930156B1 (en) | USE OF NONAPEPTIDE PAT IN THE TREATMENT OF AUTOIMMUNE DISEASES. | |
DK1773451T3 (en) | Use of 7-t-butoxyiminomethylcamptothecin in the treatment of uterine neoplasms | |
NO20052429D0 (en) | The contrast agents | |
FR2867830B1 (en) | LOCKABLE / UNLOCKABLE PIPING FITTING | |
ITMI20040989A1 (en) | USE OF SULGLICOTIDE FOR THE TREATMENT OF MUCOSITES | |
FR2902321B1 (en) | USE OF CURCUMIN FOR THE TREATMENT OF CANITIA | |
FR2918278B1 (en) | USE OF OLEOCANTHAL IN THE TREATMENT OF SKIN INFLAMMATION. | |
ITMI20051576A1 (en) | USE OF ISOTHIOCYANATES IN THE TREATMENT OF ACUTE LEUKEMIASES | |
EE200400064A (en) | Use of ambroxol for the treatment of pharyngitis | |
FR2890402B1 (en) | SEPTIC TANK | |
RU2005114733A (en) | Means for the treatment of erectile dysfunction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20100331 |